News
Hosted on MSN21d
ShiraTronics commences chronic migraine therapy trialShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for chronic migraine treatment. The US Food and Drug Administration (FDA ...
A team of researchers in China has demonstrated a novel dual-solvent process in 4-terminal carbon CsPbBr3 perovskite solar cells that achieve 10.18% power conversion efficiency. They have also built a ...
I see Gy∙cm2 and mGy on the monitor of my angiography machine. What do these represent? These are two measured dosimetric quantities that can be used to estimate the radiation risks. Gy∙cm2 is used ...
CM2 margin expands significantly to 17.6% (Q1 2024: 16.8%) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results